Stephen Ksenak Net Worth

The estimated Net Worth of Stephen Michael Ksenak is at least $2.98 millió dollars as of 7 August 2024. Mr. Ksenak owns over 5,000 units of AMBAC stock worth over $1,243,052 and over the last 12 years he sold AMBC stock worth over $0. In addition, he makes $1,741,620 as General Counsel és Senior Managing Director at AMBAC.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Ksenak AMBC stock SEC Form 4 insiders trading

Stephen has made over 44 trades of the AMBAC stock since 2013, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of AMBC stock worth $55,000 on 7 August 2024.

The largest trade he's ever made was exercising 36,351 units of AMBAC stock on 22 February 2023 worth over $387,502. On average, Stephen trades about 4,070 units every 65 days since 2013. As of 7 August 2024 he still owns at least 116,609 units of AMBAC stock.

You can see the complete history of Mr. Ksenak stock trades at the bottom of the page.

Stephen Ksenak biography

Stephen M. Ksenak serves as General Counsel, Senior Managing Director of the Company. Mr. Ksenak has executive responsibility for managing Ambac’s legal affairs. Prior to joining Ambac as Vice President and Assistant General Counsel in 2002, Mr. Ksenak practiced at the law firm of King & Spalding LLP.

What is the salary of Stephen Ksenak?

As the General Counsel és Senior Managing Director of AMBAC, the total compensation of Stephen Ksenak at AMBAC is $1,741,620. There are 3 executives at AMBAC getting paid more, with Claude LeBlanc having the highest compensation of $5,588,240.

How old is Stephen Ksenak?

Stephen Ksenak is 54, he's been the General Counsel és Senior Managing Director of AMBAC since 2011. There are 7 older and 10 younger executives at AMBAC. The oldest executive at AMBAC Financial Group Inc. is Claude Prieur, 69, who is the Independent Director.

What's Stephen Ksenak's mailing address?

Stephen's mailing address filed with the SEC is AMBAC FINANCIAL GROUP, INC., ONE WORLD TRADE CENTER, 41ST FLOOR, NEW YORK, NY, 10007.

Insiders trading at AMBAC

Over the last 2001 years, insiders at AMBAC have traded over $0 worth of AMBAC stock and bought 620,503 units worth $8,494,882 . The most active insiders traders include Claude Le Blanc, Tavakoli Nader és C James Prieur. On average, AMBAC executives and independent directors trade stock every 3430 days with the average trade being worth of $117,111. The most recent stock trade was executed by R Sharon Smith on 8 August 2024, trading 1,100 units of AMBC stock currently worth $11,704.

What does AMBAC do?

ambac financial group, inc. (“ambac”), headquartered in new york city, is a holding company whose subsidiaries, including its principal operating subsidiary, ambac assurance corporation (“ambac assurance”), everspan financial guarantee corporation, and ambac assurance uk limited, provided financial guarantees and other financial services to clients in both the public and private sectors globally. ambac assurance, including the segregated account of ambac assurance (in rehabilitation), is a guarantor of public finance and structured finance obligations. ambac is also exploring opportunities involving the development or acquisition of new financial services businesses. ambac’s common stock trades on the nasdaq global select market (nasdaq: ambc)

Complete history of Mr. Ksenak stock trades at AMBAC és AMBAC

AMBAC executives and stock owners

AMBAC executives and other stock owners filed with the SEC include:

• Claude LeBlanc,
  President, Chief Executive Officer, Director
• Claude L. LeBlanc,
  Pres, CEO & Director
• David Trick,
  Chief Financial Officer, Executive Vice President, Treasurer
• Stephen Ksenak,
  General Counsel, Senior Managing Director
• David Barranco,
  Senior Managing Director
• David Trick,
  Exec. VP, CFO & Treasurer
• R. Sharon Smith,
  Senior Managing Director, Chief of Staff
• Stephen Michael Ksenak,
  Sr. MD & Gen. Counsel
• David Peter Barranco,
  Sr. MD and Head of Risk Management & Corp. Devel.
• Rhonta Sharon Smith,
  Sr. MD & Chief of Staff
• Robert Eisman,
  Chief Accounting Officer, Senior Managing Director, Controller
• Jeffrey Stein,
  Independent Chairman of the Board
• David Herzog,
  Independent Director
• Alexander Greene,
  Independent Director
• Ian Haft,
  Independent Director
• Claude Prieur,
  Independent Director
• Joan Lamm-Tennant,
  Independent Director
• Lisa Kampf,
  Managing Director
• Michael Reilly,
  Chief Administrative Officer, Chief Information Officer, Senior Managing Director
• Kate Smith,
  Director of Corp. Communications
• Charles Joseph Sebaski,
  MD & Head of Investor Relation
• Daniel Matthew McGinnis,
  Sr. MD & COO
• Dan McGinnis,
  Sr. MD & COO
• Patrick McCormick,
  Managing Director
• Robert Bryan Eisman,
  Sr. MD, Chief Accounting Officer & Controller
• Robert G. Donovan,
  Chief Investment Officer
• Tavakoli Nader,
  Director
• C James Prieur,
  Director
• Cathleen Matanle,
  Senior Managing Director
• Eugene M Bullis,
  Director
• Victor E Mandel,
  Director
• Diana Adams,
  Chief Executive Officer
• Lisa G Iglesias,
  Director
• Michael D Price,
  Director
• Kristi Ann Matus,
  Director
• Daniel Mc Ginnis,
  Sr. MD & COO